Abstract
Cancer has always been possessing the highest mortality rate among major diseases, therefore, it is necessary and revolutionary for the research of the prevention of cancer. World Health Organization tells us that at least 30% of cancer is preventable and can be found in advance, so how to detect the cancer rapidly and sensitively has far-reaching significance. In this article, we used the UV spectrophotometric detection technology for human IgG protein and Raman spectroscopy to do a large number of experimental studies for qualitative and quantitative protein, obtained Raman spectra of characteristic protein and dyestuff, as well as UV spectrophotometer measured spectrum peak. We analyzed the experiment the get the conclusion, and established the database of the Raman spectra of proteins, so as to work in with telemedicine to improve current method of cancer's detection and diagnosis. Only with a complete test system program, will the rest of telemedicine have accurate and reliable data to support further depth promotion.
Introduction
Early detection is the "holy grail" of oncology; the World Health Organization suggests that 30% of cancers are preventable if caught early. However, current diagnostic staples have significant drawbacks. Imaging techniques like B-ultrasound and X-rays can suffer from low resolution or high costs, while endoscopies and blood draws are invasive and often uncomfortable for patients.
The authors identify a need for a rapid, sensitive, and non-invasive screening method. While researchers have looked into urine-based "cancer markers," the chemical complexity and fluctuating concentrations of bodily fluids make consistent detection difficult. This paper explores how optical "fingerprints" (spectroscopy) can be used to identify protein concentrations accurately enough to support a remote telemedicine database.
Methods
The researchers focused on Human IgG protein as a model biomarker, employing two primary optical techniques:
- UV-Spectrophotometry: This was used for quantitative analysis. Proteins containing aromatic amino acids (like tyrosine and tryptophan) naturally absorb ultraviolet light. The team measured absorbance at 278nm and 280nm across various concentrations (0.25 mg/ml to 1.25 mg/ml) to establish a linear baseline.
- Raman Spectroscopy: This was used for qualitative identification. Raman spectroscopy measures the vibrational modes of molecules, providing a unique "fingerprint."
- Sample Optimization: A key part of their method involved diluting samples in 0.9% NaCl. Interestingly, they experimented with the physical state of the sample, observing how the protein behaved when "almost dry" to improve signal clarity.
Key Results and Discussion
The UV-spectrophotometry tests confirmed a highly linear relationship between protein concentration and absorbance (RSD of 0.0000 across multiple trials), proving it is a reliable method for measuring protein levels in a lab setting.
The team successfully identified a characteristic Raman peak for human IgG at approximately 617 cm⁻¹. They determined that 278nm is the most suitable measurement wavelength for the absorption curve of human IgG when aiming for high signal-to-noise ratios.
One of the most interesting findings was that Raman detection improved significantly when the protein solution was nearly dry. Under electron microscopy, they observed that the protein and sodium chloride (salt) crystallized separately. This separation allowed the laser to hit "blue" protein clusters without the interference of the "green" salt crystals, resulting in much clearer peaks. Furthermore, in Raman spectroscopy, higher concentration isn't always better. The authors found that large protein molecules create a colloid that scatters light and produces high fluorescence, which can drown out the Raman signal. Diluting the sample actually improved the signal-to-noise ratio by weakening these fluorescent properties.
Conclusion and Future Work
The authors argue that telemedicine's success depends entirely on the reliability of the "biological snapshot" sent to the cloud. Without a standardized database of protein spectra, remote diagnosis remains speculative. The paper acknowledges several hurdles that remain before this can be deployed in a clinic, such as high equipment costs for Raman spectrometers and potential interference from other organic compounds. Future work will focus on exploring other protein types and refining the "rapid screening program" to automate the identification of these biological snapshots within the telemedicine architecture.
Summary updated